| scholarly article | Q13442814 |
| P2093 | author name string | Dirk-Jan Slebos | |
| Karin Klooster | |||
| Arschang Valipour | |||
| Chris T Bolliger | |||
| Coenraad F N Koegelenberg | |||
| Johan Theron | |||
| Martin Mayse | |||
| Dorothy Styen | |||
| P2860 | cites work | Bronchodilator responsiveness in patients with COPD. | Q46767890 |
| Development and Validation of an Improved, COPD-Specific Version of the St. George Respiratory Questionnaire. | Q51909954 | ||
| Enhanced persistence with tiotropium compared with other respiratory drugs in COPD. | Q51919626 | ||
| Tiotropium inhibits pulmonary inflammation and remodelling in a guinea pig model of COPD | Q57098846 | ||
| Increased levels of Th17 cells are associated with non-neuronal acetylcholine in COPD patients | Q59226943 | ||
| Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group | Q70936187 | ||
| Lung denervation in the therapy of intractable bronchial asthma | Q74394226 | ||
| The clinical physiology of the human bronchi. III. The effect of vagus section on the cough reflex, bronchial caliber, and clearance of bronchial secretions | Q75729664 | ||
| Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline Update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society | Q22305324 | ||
| Development, validity and responsiveness of the Clinical COPD Questionnaire | Q24800304 | ||
| Standardisation of the measurement of lung volumes | Q28269989 | ||
| Standardisation of spirometry | Q29547365 | ||
| A new approach to pulmonary emphysema | Q33602680 | ||
| ATS Statement | Q34136219 | ||
| Muscarinic receptor signaling in the pathophysiology of asthma and COPD. | Q34684230 | ||
| A 4-year trial of tiotropium in chronic obstructive pulmonary disease | Q34845834 | ||
| ATS/ACCP Statement on cardiopulmonary exercise testing | Q35043791 | ||
| Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease | Q35533189 | ||
| Cholinergic pathways in the lungs and anticholinergic therapy for chronic obstructive pulmonary disease | Q36305305 | ||
| Reflex regulation of airway smooth muscle tone | Q36489831 | ||
| Use of Respimat Soft Mist inhaler in COPD patients | Q37018826 | ||
| Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium | Q43900636 | ||
| Assessment of the pulmonary origin of bronchoconstrictor vagal tone | Q45916562 | ||
| Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD. | Q46703226 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 411-419 | |
| P577 | publication date | 2015-03-04 | |
| P1433 | published in | Thorax | Q7796158 |
| P1476 | title | Targeted lung denervation for moderate to severe COPD: a pilot study | |
| P478 | volume | 70 |
| Q87336023 | Another STEP forward in emphysema treatment |
| Q58700730 | Bronchial thermoplasty reduces gas trapping in severe asthma |
| Q57179050 | Bronchoscopic Lung Volume Reduction: A 2018 Review and Update |
| Q64947472 | Bronchoscopic treatment of emphysema: an update. |
| Q93010681 | Calming Nervous Airways: Targeted Lung Denervation for Chronic Obstructive Pulmonary Disease |
| Q89699609 | Design for a multicenter, randomized, sham-controlled study to evaluate safety and efficacy after treatment with the Nuvaira® lung denervation system in subjects with chronic obstructive pulmonary disease (AIRFLOW-3) |
| Q36063164 | Endoscopic interventions in pulmonology |
| Q61796886 | European Respiratory Society International Congress, Paris, 2018: highlights from the Clinical Assembly |
| Q54227221 | In vitro, in silico and in vivo study challenges the impact of bronchial thermoplasty on acute airway smooth muscle mass loss. |
| Q64091366 | Interventional therapy in patients with severe emphysema: evaluation of contraindications and their incidence |
| Q90429243 | Long-term safety of bilateral targeted lung denervation in patients with COPD |
| Q57172941 | Lung volume reduction with endobronchial coils for patients with emphysema |
| Q50052790 | Nerve ablation after bronchial thermoplasty and sustained improvement in severe asthma. |
| Q38570831 | Pharmacology of acute mountain sickness: old drugs and newer thinking |
| Q57787122 | Physiologic and Histopathologic Effects of Targeted Lung Denervation in an Animal Model |
| Q90110976 | Respiratory Sinus Arrhythmia Attenuation via Targeted Lung Denervation in Sheep and Humans |
| Q92566839 | Safety and Adverse Events after Targeted Lung Denervation for Symptomatic Moderate to Severe Chronic Obstructive Pulmonary Disease (AIRFLOW). A Multicenter Randomized Controlled Clinical Trial |
| Q92909134 | Safety and Dose Study of Targeted Lung Denervation in Moderate/Severe COPD Patients |
| Q33780283 | The bronchoscopic interventions for chronic obstructive pulmonary disease according to different phenotypes |
| Q38585905 | Vagus Nerve and Vagus Nerve Stimulation, a Comprehensive Review: Part III. |
Search more.